A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic ...

A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient ...

Learn about how Pomalidomide, a cancer drug, shows promise in treating hereditary hemorrhagic telangiectasia (HHT), a rare ...

A trial found the drug pomalidomide effectively treats hereditary hemorrhagic telangiectasia (HHT), reducing nosebleeds and ...

The New England Journal of Medicine published the trial results, which show that patients with HHT who were administered the ...

A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient ...

A clinical trial was stopped early after researchers found that a bone marrow cancer drug, is safe and effective for treating ...

A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of ...

Hereditary hemorrhagic telangiectasia (HHT), the world's second-most-common inherited bleeding disorder, affects ...

Bone marrow cancer drug shows success in treatment of rare blood disorder: Study: Bethesda, Maryland Friday, September 20, 2024, 16:00 Hrs [IST] A clinical trial supported by the ...

An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...

Severe nosebleeds caused by hereditary hemorrhagic telangiectasia dwinded in people who took a drug used to treat cancer.